Application of systems pharmacology modeling to explore safety issues arising at different stages of drug development
- At: 2017 FIP Congress in Stockholm (Sweden)
- Type: Presentation
- By: DEMIN, Oleg (Institute for Systems Biology Moscow, Moscow, Russian Federation)
- Co-author(s): Oleg Demin: Institute for Systems Biology Moscow, Russian Federation
The aim of this presentation is to demonstrate possible applications of systems pharmacology modeling to explore safety issues arising at different stages of drug development. Two case studies will be considered. The first one is about Behcet disease and FMF characterized by unregulated production of IL‑1 beta cytokine. A novel fusion protein.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.